Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

Author： Van Cutsem E.   Cunningham D.   Ten Bokkel Huinink W.W.   Punt C.J.A.   Alexopoulos C.G.   Dirix L.   Symann M.   Blijham G.H.   Cholet P.   Fillet G.   Van Groeningen C.   Vannetzel J.M.   Levi F.   Panagos G.   Unger C.   Wils J.   Cote C.   Blanc C.   Herait P.   Bleiberg H.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.35, Iss.1, 1999-01, pp. : 54-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

By Benavides M.   García-Alfonso P.   Cobo M.   Muñoz-Martín A.   Gil-Calle S.   Carabantes F.   Villar E.   Graupera J.   Balcells M.   Pérez-Manga G.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 255-262

Humana Press, Inc

Access to resources Recommend Favorite

Doxifluridine in Colorectal Cancer Patients Resistant to 5-Fluorouracil (5-FU) Containing Regimens

By Bajetta E.   Di Bartolomeo M.   Somma L.   Del Vecchio M.   Artale S.   Zunino F.   Bignami P.   Magnani E.   Buzzoni R.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 687-690

Elsevier

Access to resources Recommend Favorite

Phase I study of CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic colorectal cancer

By Fujishima Hiromitsu   Kikuchi Ikuo   Miyanaga Osamu   Ueda Akira   Baba Eishi   Mitsugi Kenji   Harada Mine   Nakano Shuji  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 92-97

Springer Publishing Company

Access to resources Recommend Favorite

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

By Andre T.   Louvet C.   Maindrault-Goebel F.   Couteau C.   Mabro M.   Lotz J.P.   Gilles-Amar V.   Krulik M.   Carola E.   Izrael V.   de Gramont A.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1343-1347

Elsevier

Access to resources Recommend Favorite

Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients

By Bensmane M.A.   de Gramont A.   Brienza S.   Marty M.   Levi F.   Ducreux M.   Francois E.   Gamelin E.   Bleiberg H.   Bleuzen P.   Simon J.   Cvitkovic E.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2335-2343

Elsevier

Access to resources Recommend Favorite